Skip to main content

Month: May 2024

Good start to the year driven by robust customer activity across the business and strong credit quality in uncertain environment. Net profit of DKK 5.6 billion for the first quarter of 2024

Press release  Bernstorffsgade 40DK – 1577 København VTel. +45 45 14 00 00 3 May 2024Good start to the year driven by robust customer activity across the business and strong credit quality in uncertain environmentNet profit of DKK 5.6 billion for the first quarter of 2024 Carsten Egeriis, Chief Executive Officer, comments on the financial results: “In the first three months of the year, we saw macroeconomic uncertainty remaining high, not least because of the geopolitical landscape. It is still very much a mixed picture with many areas of the Nordic economies performing well, but we also see businesses facing headwinds, for example within construction. Unemployment remains low, and households are in the process of regaining their real income. For Danske Bank, the first quarter of 2024 was a continuation of our stable and satisfactory...

Continue reading

Ayvens: Integration proceeding well and Q1 2024 financial results in line with plans

Q1 2024 RESULTS Leasing contract and Services margins at EUR 706.6 million, up 30.6% vs. Q1 2023, driven by the consolidation of LeasePlan and up 16.0% vs. Q4 20231, on the back of stabilizing underlying margins2, materialization in P&L of synergies with LeasePlan and limited non-recurring items Used car sales (UCS) result per unit at EUR 1,6613 in Q1 2024 excluding the impacts of reduction in depreciation costs and Purchase Price Allocation (PPA), stable vs. Q4 2023 (EUR 1,706). UCS result per unit at EUR 626 including the impacts of reduction in depreciation costs and PPA Cost to income ratio4 at 67.7%, improving from 68.4% in Q4 2023Cost of risk5 at 25 bps vs. 19 bps in Q4 2023Net income (group share) at EUR 187.8 million, up from EUR 28.2m in Q4 2023, which was impacted by various non-recurring itemsReturn on Tangible Equity...

Continue reading

Harvia’s Interim Report 1 January – 31 March 2024

Harvia Plc, Interim report 3 May 2024 at 9.00 a.m. EESTHarvia Q1 2024: Strong profitability − good growth outside Europe This release is a summary of Harvia Plc’s Interim Report January–March 2024. The complete report is attached to this release as a pdf file. It is also available on Harvia’s website at https://harviagroup.com/. Highlights of the review period January–March 2024:Revenue increased by 2.3% to EUR 42.4 million (41.4). At comparable exchange rates, revenue increased by 2.7% to EUR 42.5 million. Organic revenue growth was 1.4%. Operating profit was EUR 9.9 million (9.2), making up 23.3% (22.2) of the revenue. Adjusted operating profit reached EUR 10.1 million (9.3), making up 23.8% (22.4) of the revenue. At comparable exchange rates, the adjusted operating profit was EUR 10.2 million (24.0% of the revenue). Operating free...

Continue reading

Progress on ABN AMRO share buyback programme 26 April – 2 May 2024

Progress on ABN AMRO share buyback programme 26 April – 2 May 2024 ABN AMRO reports the transaction details related to its EUR 500 million share buyback programme announced on 14 February 2024. During the week of 26 April 2024 up to and including 2 May 2024 a total of 2,400,000 shares and depositary receipts were repurchased at an average price of €15.25 for a total amount of €36,590,400. For detailed information on the daily repurchased shares and depositary receipts, individual share purchase transactions and weekly reports, see the ABN AMRO website at https://www.abnamro.com/en/investor-relations/information/share-buyback-programme. To date the total consideration for shares and depositary receipts repurchased amounts to €488,662,860 representing 97.73% of the overall share buyback programme.ABN AMRO Press Office pressrelations@nl.abnamro.com+31...

Continue reading

Trading statement Q1 2024

Novonesis realized 4% organic sales growth in line with expectations and maintains 2024 outlook. Ester Baiget, President & CEO: “I am pleased with the first quarter organic sales growth of 4% with growth in both Food & Health and Planetary Health. We are off to a good start in line with expectations and very well on track to deliver 5-7% organic sales growth for the full year with an adjusted EBITDA margin of around 35%. It’s highly comforting to see our new organization’s focus on both short and long-term deliverables and developments.” Pro forma sales performance¹ (organic sales growth calculation capped for hyperinflation countries)Against a strong comparable Novonesis realized 4% pro forma organic sales growth in Q1 2024. Volumes increased by around 2% and pricing also contributed around 2%. Pro forma sales in EUR amounted...

Continue reading

Company announcement for the first quarter of 2024

Company announcement for the first quarter of 2024 Kamilla Hammerich Skytte, CEO, comments on the first quarter of 2024: “In the first quarter of 2024, Realkredit Danmark recorded a stable result of DKK 1,005 million. The positive development in the top line was attributable to the rise in interest rate levels. Net profit for the period was down DKK 58 million because of an increase in model-based loan impairment charges. As expected, housing market activity was low early in the year as a consequence of the property tax reform, which meant that many housing trades had been brought forward to late 2023. Towards the end of the first quarter of 2024, however, we saw an increase in the number of housing trades. We expect to see moderate rises in general house prices across Denmark in 2024. A fair increase in salaries and the consequent recovery...

Continue reading

BTS Group AB (publ) Interim report January – March 2024

P R E S S  R E L E A S EStockholm, May 3, 2024 Improved growth and margins, despite challenging market January 1 – March 31, 2024Net sales MSEK 619 (579). Currency adjusted growth +7%. EBITA +23%, MSEK 58 (47). EBITA margin 9.5 (8.2) %. Profit after tax +135%, MSEK 53 (23), excluding the reversed provision of earn-out +11%, MSEK 25 (23).1) Earnings per share +135%, SEK 2.75 (1.17), excluding the reversed provision of earn-out +11%, SEK 1.30 (1.17).1)”BTS’s growth and profitability improved during the first quarter due to increasing sales volumes and the efficiency measures implemented during 2023.”Jessica Skon, CEO of BTS Group AB Outlook 2024The 2024 full-year outlook is unchanged; the result (EBITA) is expected to be better than in 2023. For more information, please contact: Michael WallinHead of investor relationsBTS Group AB (publ)michael.wallin@bts.com...

Continue reading

CREDIT AGRICOLE SA: Q1-2024 Results : THE GROUP CONTINUES TO GROW

THE GROUP CONTINUES TO GROW  CASA AND CAG STATED AND UNDERLYING DATA Q1-2024             CRÉDIT AGRICOLE S.A.   CRÉDIT AGRICOLE GROUP    Stated   Underlying     Stated   UnderlyingRevenues   €6,806m+11.2% Q1/Q1   €6,797m+10.5% Q1/Q1     €9,525m+6.7% Q1/Q1   €9,475m+5.8% Q1/Q1Expenses   -€3,669m-4.5% Q1/Q1   -€3,649m-5.0% Q1/Q1     -€5,589m-5.4% Q1/Q1   -€5,569m-5.8% Q1/Q1Gross Operating Income   €3,137m+37.6% Q1/Q1   €3,148m+36.1% Q1/Q1     €3,936m+30.4% Q1/Q1   €3,906m+28.1% Q1/Q1Cost of risk   -€400m+6.9% Q1/Q1   -€380m+1.6% Q1/Q1     -€651m-18.9% Q1/Q1   -€631m+15.2% Q1/Q1Net income group share   €1,903m+55.2% Q1/Q1   €1,933m+54.7% Q1/Q1     €2,384m ...

Continue reading

Societe Generale: First quarter 2024 earnings

RESULTS AT 31 MARCH 2024Press release                                                        Paris, 3 May 2024 QUARTERLY RESULTS Quarterly revenues of EUR 6.6 billion, stable vs. Q1 23 (-0.4%), driven by very good performances of Global Banking and Investor Solutions, Private Banking and International Retail Banking, an increase in revenues and net interest income in France compared with Q4 23, despite a shift from sight deposits to remunerated savings, and a stabilisation of margins as well as the normalisation of used car sales’ results at Ayvens Cost-to-income ratio at 74.9% in Q1 24, operating expenses down -1.5% vs. Q1 23, transformation charges of around EUR 350 million Cost of risk at 27 basis points in Q1 24, provision outstanding on performing loans of EUR 3.31 billion Group net income of EUR 680 million Reported ROTE at 4.1% SOLID...

Continue reading

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $46.00 per share. The gross proceeds of the public offering are expected to be approximately $138.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Soleno has also granted the underwriters a 30-day option to purchase up to 450,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The public offering is expected to close on or about May 7, 2024, subject to market conditions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.